These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2211446)

  • 1. The effects of single and combined antibiotics on the growth of Legionella pneumophila using time-kill studies.
    Barker JE; Farrell ID
    J Antimicrob Chemother; 1990 Jul; 26(1):45-53. PubMed ID: 2211446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity and resistance of Legionella pneumophila to some antibiotics and combinations of antibiotics.
    Moffie BG; Mouton RP
    J Antimicrob Chemother; 1988 Oct; 22(4):457-62. PubMed ID: 3204075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of resistance to erythromycin, rifampicin and ciprofloxacin in 98 clinical isolates of Legionella pneumophila.
    Onody C; Matsiota-Bernard P; Nauciel C
    J Antimicrob Chemother; 1997 Jun; 39(6):815-6. PubMed ID: 9222053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of Legionella species to five antibiotics and development of resistance by exposure to erythromycin, ciprofloxacin, and rifampicin.
    Nielsen K; Bangsborg JM; Høiby N
    Diagn Microbiol Infect Dis; 2000 Jan; 36(1):43-8. PubMed ID: 10744366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory and bactericidal activities of levofloxacin, ofloxacin, erythromycin, and rifampin used singly and in combination against Legionella pneumophila.
    Baltch AL; Smith RP; Ritz W
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1661-6. PubMed ID: 7486896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Legionella pneumophila multiplication within human macrophages by fleroxacin.
    Pohlod DJ; Saravolatz LD; Somerville MM
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():49-54. PubMed ID: 3144549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro activity of a new oral streptogramin, RPR 106972, alone and in combination with rifampicin or ciprofloxacin against Legionella spp.
    Pendland SL; Killian AD; Woodward JG; Rodvold KA
    J Antimicrob Chemother; 1997 May; 39(5):651-3. PubMed ID: 9184367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in-vitro activity of moxifloxacin against Legionella species and the effects of medium on susceptibility test results.
    Ruckdeschel G; Dalhoff A
    J Antimicrob Chemother; 1999 May; 43 Suppl B():25-9. PubMed ID: 10382872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of gatifloxacin, compared with ciprofloxacin, clarithromycin, erythromycin, and rifampin, against Legionella species.
    Dubois J; St-Pierre C
    Diagn Microbiol Infect Dis; 1999 Apr; 33(4):261-5. PubMed ID: 10212753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of DNA probes to antimicrobial susceptibility testing of Legionella pneumophila.
    Reznicek M; Bale M; Pfaller M
    Diagn Microbiol Infect Dis; 1991; 14(1):7-10. PubMed ID: 2013212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro activity of RP 59500, a new synergic antibacterial agent, against Legionella spp.
    Dubois J; Joly JR
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():77-81. PubMed ID: 1399954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of levofloxacin, erythromycin or rifampicin pretreatment on growth of Legionella pneumophila in human monocytes.
    Smith RP; Baltch AL; Franke M; Hioe W; Ritz W; Michelsen P
    J Antimicrob Chemother; 1997 Nov; 40(5):673-8. PubMed ID: 9421315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-gamma and antibiotics fail to act synergistically to kill Legionella pneumophila in human monocytes.
    Bhardwaj N; Horwitz MA
    J Interferon Res; 1988 Jun; 8(3):283-93. PubMed ID: 3137275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells.
    Stout JE; Arnold B; Yu VL
    Diagn Microbiol Infect Dis; 1998 Jan; 30(1):37-43. PubMed ID: 9488830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular multiplication of Legionnaires' disease bacteria (Legionella pneumophila) in human monocytes is reversibly inhibited by erythromycin and rifampin.
    Horwitz MA; Silverstein SC
    J Clin Invest; 1983 Jan; 71(1):15-26. PubMed ID: 6848556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence in serum and lungs of guinea pigs of erythromycin, gentamicin, chloramphenicol and rifampicin and their in-vitro activities against Legionella pneumophila.
    Gibson DH; Fitzgeorge RB
    J Antimicrob Chemother; 1983 Sep; 12(3):235-44. PubMed ID: 6630106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of Legionella species to antimicrobial agents.
    Chen SC; Paul ML; Gilbert GL
    Pathology; 1993 Apr; 25(2):180-3. PubMed ID: 8367199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of Legionella pneumophila to eight antimicrobial agents including four macrolides under different assay conditions.
    Liebers DM; Baltch AL; Smith RP; Hammer MC; Conroy JV
    J Antimicrob Chemother; 1989 Jan; 23(1):37-41. PubMed ID: 2526110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bactericidal effects of amoxycillin/clavulanic acid against Legionella pneumophila.
    Stokes DH; Slocombe B; Sutherland R
    J Antimicrob Chemother; 1989 Jan; 23(1):43-51. PubMed ID: 2745255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro activity of six intracellular antibiotics against Legionella pneumophila strains of human and environmental origin.
    Reda C; Quaresima T; Pastoris MC
    J Antimicrob Chemother; 1994 Apr; 33(4):757-64. PubMed ID: 8056694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.